Bob Zollars

Bob has led eleven different healthcare and technology businesses as President or CEO, ranging in size from early stage to over $5B in annual revenue. He was the Chairman and CEO at Vocera, a publicly traded HCIT company that was recently sold to Stryker. Prior to that Bob served as the CEO of Wound Care Solutions which was merged into Healogics. Bob led Neoforma prior to that as Chairman and CEO, taking the company public and ultimately selling it to Global Health Exchange. Bob was EVP, Group President at Cardinal Health responsible for five of their wholly owned subsidiaries: Pyxis, Owen Healthcare, Medicine Shoppe, as well as their IT and International businesses. Before Cardinal, Bob led four different operating divisions of Baxter including Dietary Products, Scientific Products, IV Therapy, and US Distribution. He held a number of positions with American Hospital Supply Corporation before that company was acquired by Baxter. Bob joined Frazier Healthcare Partners as an Operating Partner in their Growth Equity business in 2015 and has chaired three Frazier portfolio company Boards: Leiters, AppianRx, and Parata Systems. He is currently a Senior Advisor to Frazier. Bob has served on over 20 corporate boards, and currently serves on the boards of Five9, Kate Farms, Recuro Health, Cubex, and Kinnos. He is a Board Fellow with the National Association of Corporate Directors (NACD) and also serves as a Trustee of Arizona State University.